ProCE Banner Activity

Treatment Options From 5 Experts on Neoadjuvant and Adjuvant Therapy for HER2-Positive Early Breast Cancer: An Online Tool

Tool

Did you recently receive a diagnosis of HER2-positive early breast cancer? Use this Interactive Decision Support Tool to view treatment plans before or after surgery from 5 breast cancer experts by answering a series of multiple choice questions about your cancer.

Released: March 19, 2019

Expiration: March 17, 2020

No longer available for credit.

Share

Faculty

Frankie Ann Holmes

Frankie Ann Holmes, MD, FACP

Medical Oncologist
US Oncology/Texas Oncology
Houston, Texas

Sara Hurvitz

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Joyce O’Shaughnessy

Joyce O’Shaughnessy, MD

Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
US Oncology
Dallas, Texas

Mark D. Pegram

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Denise A. Yardley

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee

Provided by

Provided by Postgraduate Institute for Medicine

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech TEXT Only

Partners

GRACE

ProCE Banner

Faculty Disclosure

Primary Author

Frankie Ann Holmes, MD, FACP

Medical Oncologist
US Oncology/Texas Oncology
Houston, Texas

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Joyce O’Shaughnessy, MD

Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
US Oncology
Dallas, Texas

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee

Additional Information

Program Medium

This program has been made available online.